Case Study: Development of a Global Affordability Navigator to assess affordability solution strategies for a novel treatment in ulcerative colitis (UC)
Our client was launching a novel therapy for the treatment of Ulcerative Colitis (UC) and wanted to assess the strategic potential of patient affordability solutions across 13 international markets
Case Study: Consumer willingness to pay assessment for an HPV vaccine
The client had developed and launched a human papillomavirus (HPV) vaccine which was reimbursed for adolescents through national immunization programs for only some markets
Case Study: Identification and design of affordability solutions for an innovative treatment for sickle cell disease
The client developed an innovative treatment for sickle cell disease (SCD) and wanted to assess the payer and self-pay landscape, understand barriers to funding / purchase decisions, and identify affordability solutions to support access to Product X across markets in-scope